Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

CorePharma, LLC Recalls Select Lots of Glyburide and Metformin Tablets
CorePharma, LLC is recalling several lots of Glyburide and Metformin 1.25 mg /250 mg, 2.5 mg/500 mg and 5 mg/500 mg tablets because it is possible that the tablets contain tiny pieces of metal. The following lot numbers have been recalled: 1) Glyburide and Metformin Tablets 1.25 mg/250 mg - Lot numbers CPI869, CPK819A, CPB968A, 100980, 101423B, CPK819B, CPB968B, and 101423A 2) Glyburide and Metformin Tablets 2.5 mg/500 mg - Lot numbers CPI812, CPK818 10/10, CPK829, CPA961, CPA962, CPB939, CPB940, CPB941, CPB955, CPB956, 100278, 100279, 100280, 100657, 100658, 100925, 100926, 101098, 101099, 101100, 101419, 101420, 101931, CPK816, CPK817, CPK830, CPL801, and CPB942 3) Glyburide and Metformin Tablets 5 mg/500 mg - Lot numbers CPK821C, 100281, 101564, CPK832B, CPL802B, CPK822, CPK823, CPK832, CPL802, CPL803, and CPL804 Glyburide and Metformin tablets are used in the treatment of diabetes. The combination of Glyburide and Metformin is also sold under the brand name Glucovance. This recall alert only applies to the select lots of the generic Glyburide and Metformin tablets made by CorePharma, LLC. No other lots, strengths, or brands were involved in this recall. To view the FDA notice about this recall, please visit: http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm2125
Learn More

CorePharma, LLC Recalls Select Lots of Glipizide and Metformin Tablets
CorePharma, LLC is recalling several lots of Glipizide and Metformin 2.5 mg /250 mg, 2.5 mg/500 mg and 5 mg/500 mg tablets because it is possible that the tablets contain tiny pieces of metal. The following lot numbers have been recalled: 1) Glipizide and Metformin Tablets 2.5 mg/250 mg - Lot numbers 100606 and 102466 2) Glipizide and Metformin Tablets 2.5 mg/500 mg - Lot numbers CPI870, CPB931, 100387, 100824, 101101, 101651, 102482, and 102483 3) Glipizde and Metformin Tablets 5 mg/500 mg - Lot numbers CPK825, CPB914, CPB915, 100353, 100354, 100573, 100602, 100939, 101096, 101097, 101652, 101653, 102484, 102486, and 102485 Glipizide and Metformin tablets are used in the treatment of diabetes. The combination of Glipizide and Metformin is also sold under the brand name Metaglip. This recall alert only applies to the select lots of the generic Glipizide and Metformin tablets made by CorePharma, LLC. No other lots, strengths, or brands were involved in this recall. To view the FDA notice about this recall, please visit: http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm212563.htm
Learn More

Date Published Title Drug Source
2010-06-07 CorePharma, LLC Recalls Select Lots of Glyburide and Metformin Tablets Glyburide with Metformin Hydrochloride FDA
2010-06-07 CorePharma, LLC Recalls Select Lots of Glipizide and Metformin Tablets Glipizide with Metformin FDA
2010-06-03 Updated Prescribing Information Now Available for Inhalers Used for Asthma: Serevent, Foradil, Brovana, and Others Arformoterol FDA
2010-06-01 All Lots of Four Select PediaCare Products Recalled Dextromethorphan Manufacturer
2010-06-01 All Lots of Four Select PediaCare Products Recalled Manufacturer
2010-05-27 FDA Completes Safety Review of Xenical/Alli (Orlistat) and Severe Liver Injury Orlistat FDA
2010-05-26 FDA Updates Prescribing Information for Proton Pump Inhibitors to Warn About Increased Risk of Fractures Dexlansoprazole FDA
2010-05-25 Ultram and Ultracet Prescribing Information Updated Tramadol FDA
2010-05-12 Serious Side Effects from Swallowing Topical Benadryl Product Diphenhydramine FDA
2010-05-12 Nycomed Recalls Several Different Eye Ointments Maxitrol FDA
2010-05-12 Diflorasone Cream: Nycomed Recalls Two Lots Diflorasone FDA
2010-05-12 Proton Pump Inhibitors (PPIs) May Be Linked to Bone Fractures and Bacterial Infections Omeprazole MediGuard CRT
2010-05-10 Voluntary Recall of Certain Lots of Claritin Eye Drops Ketotifen Manufacturer
2010-05-06 What Consumers Need to Know About Recalled Liquid Products for Children Cetirizine Manufacturer
2010-05-04 Medication Guide Reviews Risks of Vivitrol Naltrexone Manufacturer
2010-05-03 FDA Announces Ongoing Safety Review of Gonadotropin-Releasing Hormone (GnRH) Agonists Lupron FDA
2010-05-03 Voluntary Recall of Certain Liquid Children's and Infants' Tylenol Motrin, Zyrtec, and Benadryl Products Cetirizine Manufacturer
2010-04-26 Metoprolol: Ipca Laboratories Recalls Single Lot of Metoprolol Tartrate 50 mg Tablets Metoprolol FDA
2010-04-26 DIgoxin: West-ward Recalls Single Lot of Digoxin 125 mcg (0.125 mg) Tablets Digoxin FDA
2010-04-21 Propylthiouracil: FDA Requires Addition of Boxed Warning About Reports of Severe Liver Injury Propylthiouracil FDA
Back to Consumer Med Safety